1. Genomic Editing of Non-Coding RNA Genes with CRISPR/Cas9 Ushers in a Potential Novel Approach to Study and Treat Schizophrenia
   Chuanjun Zhuo et al, 2017, Front. Mol. Neurosci. CrossRef
2. miRNAs and their role in the correlation between schizophrenia and cancer
   E. Rizos et al, 2016 CrossRef
3. MiRNAs of peripheral blood as the biomarker of schizophrenia
   Kuanjun He et al, 2018, Hereditas CrossRef
4. The role of blood-based biomarkers in advancing personalized therapy of schizophrenia
   Junfang Chen et al, 2017, Expert Review of Precision Medicine and Drug Development CrossRef
5. Association between single nucleotide polymorphisms in MiR219-1 and MiR137 and susceptibility to schizophrenia in a Chinese population
   Ya-Jun Sun et al, 2015 CrossRef
6. Optimal consistency in microRNA expression analysis using reference-gene-based normalization
   Xi Wang et al, 2015, Mol. BioSyst. CrossRef
7. Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics
   Chi-Yu Lai et al, 2016, WJP CrossRef
8. A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia
   Kensuke Sakamoto et al, 2018, Am. J. Med. Genet. CrossRef
9. Identification of a miRNAs signature associated with exposure to stress early in life and enhanced vulnerability for schizophrenia: New insights for the key role of miR-125b-1-3p in neurodevelopmental processes
   Nadia Cattane et al, 2018, Schizophrenia Research CrossRef
10. null
    Ghiabe-Henri Guibinga, 2015 CrossRef
11. MicroRNAs 29b and 181a down-regulate the expression of the norepinephrine transporter and glucocorticoid receptors in PC12 cells
    Maoxian Deng et al, 2016, J. Neurochem. CrossRef
12. Chronically dysregulated NOTCH1 interactome in the dentate gyrus after traumatic brain injury
    Noora Puhakka et al, 2017, PLoS ONE CrossRef
13. Understanding epigenetics of schizophrenia in the backdrop of its antipsychotic drug therapy
    Babu Swathy et al, 2017, Epigenomics CrossRef
14. miRNA-Coordinated Schizophrenia Risk Network Cross-Talk With Cardiovascular Repair and Opposed Gliomagenesis
    Hongbao Cao et al, 2020, Front. Genet. CrossRef
15. The Long-Term Effects of Early Life Stress on the Modulation of miR-19 Levels
    Monica Mazzelli et al, 2020, Front. Psychiatry CrossRef
16. null
    Nesma Elsayed Abdelaal et al, 2021 CrossRef
17. Peripheral Blood-Based Gene Expression Studies in Schizophrenia: A Systematic Review
    Vipul Vilas Wagh et al, 2021, Front. Genet. CrossRef
18. null
    Krithika Bhuvaneshwar et al, 2021 CrossRef
19. Disclosing common biological signatures and predicting new therapeutic targets in schizophrenia and obsessive–compulsive disorder by integrated bioinformatics analysis
    Abdolhakim Ghanbarzehi et al, 2023, BMC Psychiatry CrossRef
20. MicroRNAs as potential biomarkers for diagnosis of schizophrenia and influence of antipsychotic treatment
    Bridget Martinez et al, 2024 CrossRef
21. Noncoding RNA-targeted treatment for schizophrenia: CRISPR/CAS9
    Çağatay Özulu et al, 2021, D J Med Sci CrossRef
22. Translational bioinformatics and data science for biomarker discovery in mental health: an analytical review
    Krithika Bhuvaneshwar et al, 2024 CrossRef
23. null
    Mohammed Kaleem et al, 2024 CrossRef
24. CRISPR/Cas9 Technology for Non-Coding Gene Editing in Schizophrenia Therapeutics: The Recent Progress And Challenges
    Khushi Raj Mittal et al, 2024, CPRR CrossRef